Securian Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,099
| Closed | -$296K | – | 985 |
|
2021
Q3 | $296K | Sell |
1,099
-18
| -2% | -$4.85K | 0.01% | 907 |
|
2021
Q2 | $288K | Sell |
1,117
-29
| -3% | -$7.48K | 0.01% | 922 |
|
2021
Q1 | $344K | Buy |
1,146
+12
| +1% | +$3.6K | 0.01% | 881 |
|
2020
Q4 | $289K | Sell |
1,134
-24
| -2% | -$6.12K | 0.01% | 878 |
|
2020
Q3 | $288K | Sell |
1,158
-39
| -3% | -$9.7K | 0.01% | 846 |
|
2020
Q2 | $416K | Sell |
1,197
-7
| -0.6% | -$2.43K | 0.01% | 737 |
|
2020
Q1 | $322K | Hold |
1,204
| – | – | 0.01% | 758 |
|
2019
Q4 | $390K | Buy |
1,204
+15
| +1% | +$4.86K | 0.01% | 849 |
|
2019
Q3 | $325K | Hold |
1,189
| – | – | 0.01% | 891 |
|
2019
Q2 | $635K | Buy |
1,189
+17
| +1% | +$9.08K | 0.01% | 697 |
|
2019
Q1 | $591K | Buy |
1,172
+10
| +0.9% | +$5.04K | 0.01% | 718 |
|
2018
Q4 | $573K | Sell |
1,162
-22
| -2% | -$10.8K | 0.02% | 684 |
|
2018
Q3 | $1.08M | Buy |
1,184
+97
| +9% | +$88.7K | 0.03% | 549 |
|
2018
Q2 | $796K | Sell |
1,087
-14
| -1% | -$10.3K | 0.02% | 616 |
|
2018
Q1 | $1.75M | Buy |
+1,101
| New | +$1.75M | 0.05% | 369 |
|